Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 21627 | 354 | 42.7 | 79% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | BACLOFEN | Author keyword | 15 | 10% | 40% | 140 |
| 2 | CGP44532 | Author keyword | 6 | 80% | 1% | 4 |
| 3 | POSTSYNAPTIC DOPAMINE RECEPTOR SUPERSENSITIVITY | Author keyword | 6 | 80% | 1% | 4 |
| 4 | RAC BHFF | Author keyword | 4 | 75% | 1% | 3 |
| 5 | GS39783 | Author keyword | 4 | 41% | 2% | 7 |
| 6 | BIOMED BIMOL SCI | Address | 3 | 100% | 1% | 3 |
| 7 | GAMMA VINYL GABA VIGABATRIN | Author keyword | 3 | 100% | 1% | 3 |
| 8 | POSITIVE ALLOSTERIC MODULATORS OF THE GABAB RECEPTOR | Author keyword | 3 | 100% | 1% | 3 |
| 9 | SARDINIAN ALCOHOL PREFERRING SP RATS | Author keyword | 2 | 25% | 2% | 8 |
| 10 | BACLOFENE | Author keyword | 2 | 67% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | HIGH DOSE BACLOFEN | 31 | 63% | 9% | 31 |
| 2 | ETHANOL STIMULATED ACTIVITY | 14 | 100% | 2% | 7 |
| 3 | DISCRETE TRIALS PROCEDURE | 12 | 46% | 5% | 19 |
| 4 | RECEPTOR AGONIST BACLOFEN | 5 | 63% | 1% | 5 |
| 5 | GABAB RECEPTOR AGONISTS | 5 | 38% | 3% | 10 |
| 6 | PREFERRING SP RATS | 4 | 24% | 4% | 13 |
| 7 | AGONIST BACLOFEN | 3 | 21% | 4% | 15 |
| 8 | BACLOFEN ATTENUATES COCAINE | 3 | 57% | 1% | 4 |
| 9 | MODULATES ETHANOL INTAKE | 3 | 100% | 1% | 3 |
| 10 | RECEPTOR AGONISTS BACLOFEN | 3 | 100% | 1% | 3 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Baclofen for alcohol withdrawal | 2015 | 1 | 32 | 56% |
| GABA(B) receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidence | 2014 | 7 | 94 | 55% |
| Efficacy and Tolerability of Baclofen in Substance Use Disorders: A Systematic Review | 2013 | 7 | 148 | 50% |
| Safety and Efficacy of Baclofen in the Treatment of Alcohol-Dependent Patients | 2010 | 28 | 39 | 56% |
| GABA(B) receptor agonists for the treatment of drug addiction: a review of recent findings | 2002 | 164 | 60 | 42% |
| Defining the Role of Baclofen for the Treatment of Alcohol Dependence A Systematic Review of the Evidence | 2012 | 21 | 39 | 36% |
| GABA(B) receptors in drug addiction | 2008 | 26 | 158 | 40% |
| Baclofen: a new drug for the treatment of alcohol dependence | 2006 | 32 | 43 | 47% |
| Baclofen for alcohol withdrawal | 2013 | 1 | 25 | 52% |
| Targeting GABA(B) receptors for anti-abuse drug discovery | 2014 | 1 | 92 | 46% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | BIOMED BIMOL SCI | 3 | 100% | 0.8% | 3 |
| 2 | CS A | 1 | 40% | 0.6% | 2 |
| 3 | G FONTANA STUDY TREATMENT ALCOHOL ADDICT | 1 | 27% | 0.8% | 3 |
| 4 | ALCOHOL SUBST ABUSE PROGRAM | 1 | 50% | 0.3% | 1 |
| 5 | BIOCHEM THER EUT SCI | 1 | 50% | 0.3% | 1 |
| 6 | DAQIAO BRANCH | 1 | 50% | 0.3% | 1 |
| 7 | FES LZTACALA | 1 | 50% | 0.3% | 1 |
| 8 | GENNERUXI MED | 1 | 50% | 0.3% | 1 |
| 9 | POISONS SUBST ABUSE TREATMENT | 1 | 50% | 0.3% | 1 |
| 10 | PRECLIN PHARMCOL SECT | 1 | 50% | 0.3% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000281405 | GABAB RECEPTOR//GABAB RECEPTORS//BACLOFEN |
| 2 | 0.0000149755 | CONDITIONED PLACE PREFERENCE//PLACE CONDITIONING//INTRACRANIAL SELF ADMINISTRATION |
| 3 | 0.0000132466 | ACAMPROSATE//NALTREXONE//NALMEFENE |
| 4 | 0.0000124810 | NEURONAL NETWORKS SECT//PARS RETICULATA//BURST FIRING |
| 5 | 0.0000122493 | VIGABATRIN//VISUAL FIELD CONSTRICTION//GAMMA VINYL GABA |
| 6 | 0.0000115590 | INTRATHECAL BACLOFEN//SPASTICITY//SELECTIVE DORSAL RHIZOTOMY |
| 7 | 0.0000115181 | REINSTATEMENT//SELF ADMINISTRATION//BEHAV NEUROSCI BRANCH |
| 8 | 0.0000106479 | VENTRAL PALLIDUM//STRIATOPALLIDUM//ORAL CRANIOMAXILLO IAL RE IYODA KU |
| 9 | 0.0000104198 | LD PIPECOLIC ACID//PIPECOLIC ACID//L PIPECOLIC ACID |
| 10 | 0.0000096538 | PORTLAND ALCOHOL//ALCOHOL//ALCOHOL PREFERENCE |